investors
With a rapidly growing business in Europe and plans for a future launch in the US, Sedana Medical is well-positioned for the future.
We are well on the way to our vision of making inhaled sedation a standard therapy in critical care.
- Johan Spetz
- CFO and Head of Investor Relations
- ir@sedanamedical.com
The Share
Press Releases
2026
2026-04-24 14:00
The board of directors of Sedana Medical AB (publ) has resolved to convene an annual general meeting of shareholders to be held Wednesday, 27 May 2026...
2026-04-23 07:00
Positive Group EBITDA despite market headwinds First quarter 2026 CEO comments Positive Group EBITDA despite market headwinds In the first quarter of 2026...
2026-04-14 18:00
Sedana Medical AB’s (publ) Annual Report describes important events and financial information for 2025, as well as the progress the company has made...

